Brainstorm Cell Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Brainstorm Cell Stock Summary

Brainstorm Cell competes with Protalix Biotherapeutics, Corvus Pharmaceuticals, Aldeyra, Checkpoint Therapeutics, and Werewolf Therapeutics. Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York. Brainstorm Cell operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 43 people.

Brainstorm Cell Key Financial Ratios

Brainstorm Cell Key Balance Sheet Accounts

Brainstorm Cell Key Income Statement Accounts

Brainstorm Cell Key Cash Accounts

Brainstorm Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Brainstorm Cell's current stock value. Our valuation model uses many indicators to compare Brainstorm Cell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brainstorm Cell competition to find correlations between indicators driving Brainstorm Cell's intrinsic value. More Info.Brainstorm Cell Therapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . As of now, Brainstorm Cell's Return On Equity is increasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brainstorm Cell's earnings, one of the primary drivers of an investment's value.

Brainstorm Cell Ther Systematic Risk

Today, most investors in Brainstorm Cell Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Brainstorm Cell's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Brainstorm Cell growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Brainstorm Cell help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Brainstorm Cell Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Brainstorm Cell Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Brainstorm Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Brainstorm Cell's daily price indicators and compare them against related drivers.

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.